3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Uterine Cervical Neoplasms
7
Colorectal Neoplasms
7
Neoplasms
6
Breast Neoplasms
6
Lung Neoplasms
4
Uterine Cervical Dysplasia
2
Prostatic Neoplasms
2
Papillomavirus Infections
2
End Stage Liver Disease
2
Warts
1
Urinary Bladder Neoplasms
1
Tinea
1
Smoking
1
Skin Neoplasms
1
Pancreatic Neoplasms
1
Nevus
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Molluscum Contagiosum
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Cancer Screening
1
Liver Neoplasms
1
Kidney Failure, Chronic
1
Keratosis, Actinic
1
Intestinal Neoplasms
1
Impetigo
1
Herpes Zoster
1
Hepatitis C
1
Heart Diseases
1
Interventions
pembrolizumab
155
Gemcitabine
139
Capecitabine
121
Paclitaxel
118
Fluorouracil
116
Oxaliplatin
110
Bevacizumab
104
Nivolumab
97
Leucovorin
97
Docetaxel
92
Cisplatin
89
Irinotecan
87
Carboplatin
84
Radiosurgery
83
Cyclophosphamide
70
Cetuximab
70
Magnetic Resonance Spectroscopy
68
Trastuzumab
56
Specimen Handling
56
Biopsy
56
Radiotherapy
55
Ipilimumab
52
Everolimus
48
Pemetrexed
46
Drug Therapy
45
Albumin-Bound Paclitaxel
44
130-nm albumin-bound paclitaxel
43
Doxorubicin
41
Fulvestrant
38
aldesleukin
37
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasm Metastasis
×
Mass Screening
×
Clear all
NCT04143230
2019-10-29
SST2017
A.O.U. Città della Salute e della Scienza
Phase NA
Completed
660 enrolled